Box Hill North, Australia

Peter Agapitos Kambouris


Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Kew, AU (2001)
  • Box Hill North, AU (2001 - 2006)

Company Filing History:


Years Active: 2001-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations of Peter Agapitos Kambouris

Introduction

Peter Agapitos Kambouris is an accomplished inventor based in Box Hill North, Australia. He has made significant contributions to the field of biomedical engineering, particularly in the development of hydrophilic compositions for medical applications. With a total of four patents to his name, Kambouris has demonstrated a commitment to advancing technology in healthcare.

Latest Patents

Kambouris's latest patents include innovative hydrophilic biomedical compositions. One of his notable inventions is a hydrophilic ethylenically unsaturated macromonomer, which is prepared through the addition polymerization of monomers that possess hydroxyl or amino functional groups. This macromonomer can be utilized to create intraocular lenses in situ, providing a potential treatment for presbyopia. Another patent focuses on a similar hydrophilic ethylenically unsaturated macromonomer, emphasizing its application in forming intraocular lenses through polymerization.

Career Highlights

Throughout his career, Kambouris has worked with prestigious institutions, including the University of Melbourne and the Commonwealth Scientific and Industrial Research Organisation. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kambouris has had the opportunity to work alongside notable colleagues such as David Henry Solomon and Mark Graham Looney. These collaborations have further enriched his research and innovation efforts.

Conclusion

Peter Agapitos Kambouris is a prominent inventor whose work in hydrophilic biomedical compositions has the potential to transform medical treatments. His dedication to innovation and collaboration continues to drive advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…